{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:42:21Z","timestamp":1789620141185,"version":"build-2803163510"},"reference-count":77,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T00:00:00Z","timestamp":1564790400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Polycystic ovary syndrome (PCOS) has reproductive and metabolic aspects that may affect bone health. Controversial results from different studies regarding the risk of fractures, bone mineral density (BMD) or bone markers led to uncertainty whether PCOS might improve or deteriorate bone health.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>OBJECTIVE AND RATIONALE<\/jats:title>\n                  <jats:p>This study aimed to investigate the impact of PCOS on bone markers, BMD and fracture risk.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SEARCH METHODS<\/jats:title>\n                  <jats:p>A systematic review and a meta-analysis were carried out. PubMed, EMBASE and Cochrane databases were searched for eligible studies from 1st of January of 1990 to 9th of October of 2018. Eligible studies enrolled women older than 18\u00a0years with PCOS, which should be diagnosed according to the Rotterdam Consensus, the Androgen Excess Society, the National Institutes of Health Consensus or the International Classification of Diseases. The studies were grouped according to patient mean BMI: &lt;27\u00a0kg\/m2 or \u226527\u00a0kg\/m2. The results were polled as mean difference (MD), standardized MD (SMD) and hazard ratio (HR).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>OUTCOMES<\/jats:title>\n                  <jats:p>Overall, 921 studies were retrieved, and 31 duplicated studies were removed. After screening the titles and abstracts, 80 studies were eligible for full text reading. Of those, 23 studies remained for qualitative synthesis. With the exception of one study, all studies were considered high quality based on the Newcastle\u2013Ottawa scale (NOS; score \u22656). Meta-analysis was performed in 21 studies, with a total of 31\u2009383 women with PCOS and 102\u2009797 controls. Women with PCOS with BMI &lt;27\u00a0kg\/m2 had lower BMD of the total femur (MD, \u22120.04; 95% CI, \u22120.07 to 0.00; I2\u00a0=\u200931%; P\u00a0=\u20090.22) and spine (MD, \u22120.07; 95% CI, \u22120.13 to \u22120.01; I2\u00a0=\u200970%; P\u00a0&lt;\u20090.01) when compared with the control group, whereas for women with BMI \u226527\u00a0kg\/m2 no difference was observed (femur: MD, 0.02; 95% CI, \u22120.02 to 0.05; I2\u00a0=\u200920%, P\u00a0=\u20090.29; spine: MD, 0.02; 95% CI, \u22120.06 to 0.05; I2\u00a0=\u20090%; P\u00a0=\u20090.84). Osteocalcin was remarkably reduced in women with PCOS with BMI &lt;27\u00a0kg\/m2 (SMD, \u22122.68; 95% CI, \u22124.70 to \u22120.67; I2\u00a0=\u200998%; P\u00a0&lt;\u20090.01), but in women with BMI \u226527\u00a0kg\/m2, there were no differences between PCOS and controls. Few studies (n\u00a0=\u20093) addressed the incidence of bone fractures in women with PCOS. The HR for total bone fractures did not identify differences between women with PCOS and controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS<\/jats:title>\n                  <jats:p>On the basis of the available evidence, it is possible to assume that PCOS in women with BMI &lt;27\u00a0kg\/m2 is associated with reduced BMD in the spine and femur, and decreased bone formation, as manifested by lower levels of circulating osteocalcin. These findings suggest that bone parameters in PCOS may be linked, to some extent, to adiposity. These studies included premenopausal women, who have already achieved peak bone mass. Hence, further prospective studies are necessary to clarify the existence of increased risk of fractures in women with PCOS.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humupd\/dmz020","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T15:17:43Z","timestamp":1556896663000},"page":"634-646","source":"Crossref","is-referenced-by-count":42,"title":["Negative impact of polycystic ovary syndrome on bone health: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"25","author":[{"given":"J\u00falia Mottecy","family":"Piovezan","sequence":"first","affiliation":[{"name":"Post Graduation Program, Health Sciences Professional Master, Health Science Center, Federal University of Santa Maria, Santa Maria, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa Orlandin","family":"Premaor","sequence":"additional","affiliation":[{"name":"Post Graduation Program, Health Sciences Professional Master, Health Science Center, Federal University of Santa Maria, Santa Maria, Brazil"},{"name":"Department of Clinical Medicine, Health Science Center, Federal University of Santa Maria, Santa Maria, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2726-233X","authenticated-orcid":false,"given":"F\u00e1bio Vasconcellos","family":"Comim","sequence":"additional","affiliation":[{"name":"Post Graduation Program, Health Sciences Professional Master, Health Science Center, Federal University of Santa Maria, Santa Maria, Brazil"},{"name":"Department of Clinical Medicine, Health Science Center, Federal University of Santa Maria, Santa Maria, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,8,2]]},"reference":[{"key":"2019091315503690300_ref1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2265.1998.3691182.x","article-title":"Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women","volume":"48","author":"Adami","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019091315503690300_ref74","first-page":"261","article-title":"Polycystic ovary syndrome in university students: occurrence and associated factors","volume":"8","author":"Attlee","year":"2014","journal-title":"Int J Fertil Steril"},{"key":"2019091315503690300_ref2","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2019091315503690300_ref3","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019091315503690300_ref4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00774-013-0560-8","article-title":"Association of plasma GDF-9 or GDF-15 levels with bone parameters in polycystic ovary syndrome","volume":"33","author":"Berberoglu","year":"2015","journal-title":"J Bone Miner Metab"},{"key":"2019091315503690300_ref5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000342561","article-title":"Metabolic syndrome and central fat distribution are related to lower serum osteocalcin concentrations","volume":"62","author":"Bezerra dos Santos Magalhaes","year":"2013","journal-title":"Ann Nutr Metab"},{"key":"2019091315503690300_ref6","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jdiacomp.2017.01.023","article-title":"Association between osteocalcin gamma-carboxylation and insulin resistance in overweight and obese postmenopausal women","volume":"31","author":"Bonneau","year":"2017","journal-title":"J Diabetes Complications"},{"key":"2019091315503690300_ref7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1210\/jc.2009-0265","article-title":"Serum markers of bone turnover are increased at six and 18 months after Roux-en-Y bariatric surgery: correlation with the reduction in leptin","volume":"95","author":"Bruno","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019091315503690300_ref8","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1530\/EJE-07-0887","article-title":"Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency","volume":"158","author":"Chakhtoura","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"2019091315503690300_ref9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0889-8529(05)70076-1","article-title":"Diagnosis of polycystic ovary syndrome","volume":"28","author":"Chang","year":"1999","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2019091315503690300_ref10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3109\/13625187.2013.811483","article-title":"Short-term effects of an oral contraceptive containing oestradiol valerate and dienogest on bone metabolism and bone mineral density: an observational, preliminary study","volume":"18","author":"Di Carlo","year":"2013","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"2019091315503690300_ref11","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1139\/H08-033","article-title":"Associations of oral contraceptive use and dietary restraint with bone speed of sound and bone turnover in university-aged women","volume":"33","author":"Di Giovanni","year":"2008","journal-title":"Appl Physiol Nutr Metab"},{"key":"2019091315503690300_ref12","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"key":"2019091315503690300_ref13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00774-010-0211-2","article-title":"Serum concentrations of carboxylated osteocalcin are increased and associated with several components of the polycystic ovarian syndrome","volume":"29","author":"Diamanti-Kandarakis","year":"2011","journal-title":"J Bone Miner Metab"},{"key":"2019091315503690300_ref14","first-page":"15","article-title":"OsteocalcinGPRC6A: an update of its clinical and biological multiorganic interactions (review)","volume":"19","author":"Diaz-Franco","year":"2019","journal-title":"Mol Med Rep"},{"key":"2019091315503690300_ref15","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.fertnstert.2018.01.038","article-title":"Androgen excess- polycystic ovary syndrome society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome","volume":"109","author":"Dokras","year":"2018","journal-title":"Fertil Steril"},{"key":"2019091315503690300_ref16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019091315503690300_ref17","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1515\/JPEM.2008.21.12.1155","article-title":"Bone mineral density in girls with classical congenital adrenal hyperplasia due to CYP21 deficiency","volume":"21","author":"Elnecave","year":"2008","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2019091315503690300_ref18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"2019091315503690300_ref19","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.1073\/pnas.0711119105","article-title":"Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice","volume":"105","author":"Ferron","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019091315503690300_ref20","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cell.2010.06.003","article-title":"Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism","volume":"142","author":"Ferron","year":"2010","journal-title":"Cell"},{"key":"2019091315503690300_ref21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.fertnstert.2011.11.029","article-title":"Does PCOS have developmental origins","volume":"97","author":"Franks","year":"2012","journal-title":"Fertil Steril"},{"key":"2019091315503690300_ref22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cell.2010.06.002","article-title":"Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition","volume":"142","author":"Fulzele","year":"2010","journal-title":"Cell"},{"key":"2019091315503690300_ref23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s12098-015-1835-y","article-title":"Correlation of bone mineral parameters with anthropometric measurements and the effect of glucocorticoids on bone mineral parameters in congenital adrenal hyperplasia","volume":"83","author":"Ganesh","year":"2016","journal-title":"Indian J Pediatr"},{"key":"2019091315503690300_ref77","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/dmrr.2767","article-title":"The relationships of irisin with bone mineral density and body composition in PCOS patients","volume":"32","author":"Gao","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"2019091315503690300_ref24","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/806895","article-title":"Bone mineral density in children and adolescents with congenital adrenal hyperplasia","volume":"2014","author":"Garcia Alves Junior","year":"2014","journal-title":"Int J Endocrinol"},{"key":"2019091315503690300_ref25","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1210\/jc.2007-2249","article-title":"Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial","volume":"93","author":"Glintborg","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019091315503690300_ref26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0015-0282(99)00203-4","article-title":"Bone mineral density and body composition in lean women with polycystic ovary syndrome","volume":"72","author":"Good","year":"1999","journal-title":"Fertil Steril"},{"key":"2019091315503690300_ref27","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6823-13-11","article-title":"Reference intervals for serum osteocalcin concentrations in adult men and women from the study of health in Pomerania","volume":"13","author":"Hannemann","year":"2013","journal-title":"BMC Endocr Disord"},{"key":"2019091315503690300_ref28","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.bone.2009.12.020","article-title":"Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1","volume":"46","author":"Huang","year":"2010","journal-title":"Bone"},{"key":"2019091315503690300_ref29","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"2019091315503690300_ref30","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000479371","article-title":"An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence","volume":"88","author":"Ibanez","year":"2017","journal-title":"Horm Res Paediatr"},{"key":"2019091315503690300_ref31","first-page":"835","article-title":"Adiponectin and bone metabolism markers in female rowers: eumenorrheic and oral contraceptive users","volume":"34","author":"Jurimae","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"2019091315503690300_ref32","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1038\/s41598-017-03685-x","article-title":"Competing factors link to bone health in polycystic ovary syndrome: chronic low-grade inflammation takes a toll","volume":"7","author":"Kalyan","year":"2017","journal-title":"Sci Rep"},{"key":"2019091315503690300_ref33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/09513590.2016.1250256","article-title":"Determinants of low bone mineral density in premenopausal polycystic ovary syndrome patients","volume":"33","author":"Karadag","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"2019091315503690300_ref34","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/humrep\/deq149","article-title":"Augmentation of cortical bone mineral density in women with polycystic ovary syndrome: a peripheral quantitative computed tomography (pQCT) study","volume":"25","author":"Kassanos","year":"2010","journal-title":"Hum Reprod"},{"key":"2019091315503690300_ref35","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s40618-014-0175-5","article-title":"Bone mineral density in women with polycystic ovary syndrome","volume":"37","author":"Katulski","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"2019091315503690300_ref75","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0378-5122(01)00205-5","article-title":"Body composition characteristics are associated with the bone density of the proximal femur end in middle- and old-aged women and men","volume":"39","author":"Kirchengast","year":"2001","journal-title":"Maturitas"},{"key":"2019091315503690300_ref36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12020-017-1384-4","article-title":"Association between serum osteocalcin and body mass index: a systematic review and meta-analysis","volume":"58","author":"Kord-Varkaneh","year":"2017","journal-title":"Endocrine"},{"key":"2019091315503690300_ref37","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1530\/JOE-16-0405","article-title":"Hormonal alterations in PCOS and its influence on bone metabolism","volume":"232","author":"Krishnan","year":"2017","journal-title":"J Endocrinol"},{"key":"2019091315503690300_ref38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204748","article-title":"Vitamin D and metabolic disturbances in polycystic ovary syndrome (PCOS): a cross-sectional study","volume":"13","author":"Krul-Poel","year":"2018","journal-title":"PLoS One"},{"key":"2019091315503690300_ref39","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","article-title":"Endocrine regulation of energy metabolism by the skeleton","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"key":"2019091315503690300_ref40","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/cen.13456","article-title":"Bone markers in polycystic ovary syndrome: a multicentre study","volume":"87","author":"Lingaiah","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019091315503690300_ref41","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/BF01626606","article-title":"Cortical thickness assessed by peripheral quantitative computed tomography: accuracy evaluated on radius specimens","volume":"5","author":"Louis","year":"1995","journal-title":"Osteoporos Int"},{"key":"2019091315503690300_ref42","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jocd.2016.10.007","article-title":"Women with polycystic ovary syndrome have comparable hip bone geometry to age-matched control women","volume":"21","author":"McBreairty","year":"2018","journal-title":"J Clin Densitom"},{"key":"2019091315503690300_ref43","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJMcp1514916","article-title":"Polycystic ovary syndrome","volume":"375","author":"McCartney","year":"2016","journal-title":"N Engl J Med"},{"key":"2019091315503690300_ref44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0306-9877(95)90112-4","article-title":"Anabolic effects of insulin on bone suggest a role for chromium picolinate in preservation of bone density","volume":"45","author":"McCarty","year":"1995","journal-title":"Med Hypotheses"},{"key":"2019091315503690300_ref45","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/jbmr.2890","article-title":"Longitudinal trajectories of television watching across childhood and adolescence predict bone mass at age 20 years in the Raine study","volume":"31","author":"McVeigh","year":"2016","journal-title":"J Bone Miner Res"},{"key":"2019091315503690300_ref46","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0015-0282(98)00536-6","article-title":"Adrenal androgen excess in hyperandrogenism: relation to age and body mass","volume":"71","author":"Moran","year":"1999","journal-title":"Fertil Steril"},{"key":"2019091315503690300_ref47","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1530\/EJE-14-0158","article-title":"Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease","volume":"171","author":"Muscogiuri","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"2019091315503690300_ref48","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"Norman","year":"2007","journal-title":"Lancet"},{"key":"2019091315503690300_ref49","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejogrb.2004.01.031","article-title":"The association of bone mineral density with insulin resistance in patients with polycystic ovary syndrome","volume":"115","author":"Noyan","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2019091315503690300_ref50","first-page":"275","article-title":"Bone mineral status, bone turnover markers and vitamin D status in children with congenital adrenal hyperplasia","volume":"37","author":"Okten","year":"2012","journal-title":"Minerva Endocrinol"},{"key":"2019091315503690300_ref51","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fimmu.2014.00048","article-title":"Classical and paradoxical effects of TNF-alpha on bone homeostasis","volume":"5","author":"Osta","year":"2014","journal-title":"Front Immunol"},{"key":"2019091315503690300_ref52","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1757-2215-6-4","article-title":"Serum under-carboxylated osteocalcin levels in women with polycystic ovary syndrome: weight-dependent relationships with endocrine and metabolic traits","volume":"6","author":"Pepene","year":"2013","journal-title":"J Ovarian Res"},{"key":"2019091315503690300_ref53","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/jbmr.390","article-title":"GPRC6A mediates responses to osteocalcin in beta-cells in vitro and pancreas in vivo","volume":"26","author":"Pi","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2019091315503690300_ref54","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1530\/EJE-14-0094","article-title":"Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study","volume":"171","author":"Ramezani Tehrani","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"2019091315503690300_ref55","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2862","article-title":"Carboxylated and undercarboxylated osteocalcin in metabolic complications of human obesity and prediabetes","volume":"33","author":"Razny","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"key":"2019091315503690300_ref56","first-page":"21","article-title":"Estimation of influence of congenital-adrenal hyperplasia treatment on bone mineralisation evaluated with densitometry","volume":"18","author":"Romanowska","year":"2012","journal-title":"Pediatr Endocrinol Diabetes Metab"},{"key":"2019091315503690300_ref57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"2019091315503690300_ref58","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/jbmr.2737","article-title":"Fracture risk is decreased in women with polycystic ovary syndrome: a register-based and population-based cohort study","volume":"31","author":"Rubin","year":"2016","journal-title":"J Bone Miner Res"},{"key":"2019091315503690300_ref73","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1210\/jc.2010-2959","article-title":"Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls","volume":"96","author":"Schmidt","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2019091315503690300_ref59","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2265.2012.04378.x","article-title":"Body composition, bone mineral density and fractures in late postmenopausal women with polycystic ovary syndrome\u2014a long-term follow-up study","volume":"77","author":"Schmidt","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019091315503690300_ref60","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1210\/jc.2005-2823","article-title":"Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency","volume":"91","author":"Sciannamblo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019091315503690300_ref61","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1210\/jc.2002-021074","article-title":"Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia","volume":"88","author":"Stikkelbroeck","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019091315503690300_ref62","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"key":"2019091315503690300_ref63","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00198-015-3440-3","article-title":"The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations","volume":"27","author":"Weaver","year":"2016","journal-title":"Osteoporos Int"},{"key":"2019091315503690300_ref64","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00198-010-1180-y","article-title":"Oral contraceptive use and bone mass in women aged 26\u201336 years","volume":"22","author":"Wei","year":"2011","journal-title":"Osteoporos Int"},{"key":"2019091315503690300_ref65","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11914-010-0037-9","article-title":"Oral contraceptive use and bone","volume":"9","author":"Wei","year":"2011","journal-title":"Curr Osteoporos Rep"},{"key":"2019091315503690300_ref66","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00774-017-0894-8","article-title":"Increased risk of fractures in patients with polycystic ovary syndrome: a nationwide population-based retrospective cohort study","volume":"36","author":"Yang","year":"2018","journal-title":"J Bone Miner Metab"},{"key":"2019091315503690300_ref76","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s007740170029","article-title":"Relationship between bone mineral density and insulin resistance in polycystic ovary syndrome","volume":"19","author":"Yuksel","year":"2001","journal-title":"J Bone Miner Metab"},{"key":"2019091315503690300_ref67","first-page":"377","author":"Zawadski","year":"1992"},{"key":"2019091315503690300_ref68","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1210\/jcem.85.10.6902","article-title":"Bone mineral density, androgens, and the polycystic ovary: the complex and controversial issue of androgenic influence in female bone","volume":"85","author":"Zborowski","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019091315503690300_ref69","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.tem.2018.09.005","article-title":"Central obesity, faster maturation, and 'PCOS' in girls","volume":"29","author":"de Zegher","year":"2018","journal-title":"Trends Endocrinol Metab"},{"key":"2019091315503690300_ref70","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/jbmr.2138","article-title":"Maternal vitamin D status during pregnancy and bone mass in offspring at 20 years of age: a prospective cohort study","volume":"29","author":"Zhu","year":"2014","journal-title":"J Bone Miner Res"},{"key":"2019091315503690300_ref71","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.fertnstert.2018.09.013","article-title":"Metabolic disturbances in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"111","author":"Zhu","year":"2019","journal-title":"Fertil Steril"},{"key":"2019091315503690300_ref72","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2265.2008.03518.x","article-title":"Bone mineral density and bone turnover in Romanian children and young adults with classical 21-hydroxylase deficiency are influenced by glucocorticoid replacement therapy","volume":"71","author":"Zimmermann","year":"2009","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Human Reproduction Update"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humupd\/article-pdf\/25\/5\/634\/30011880\/dmz020.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T15:51:02Z","timestamp":1568389862000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humupd\/article\/25\/5\/634\/5542346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,2]]},"references-count":77,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,8,2]]},"published-print":{"date-parts":[[2019,9,11]]}},"URL":"https:\/\/doi.org\/10.1093\/humupd\/dmz020","relation":{},"ISSN":["1355-4786","1460-2369"],"issn-type":[{"value":"1355-4786","type":"print"},{"value":"1460-2369","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,9]]},"published":{"date-parts":[[2019,8,2]]}}}